TVTX
Travere Therapeutics, Inc.
$58.36
+0.51 (+0.88%)
At close · Jul 8
Market Cap
$5.43B
Shares
92,992,905
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-07-09 | 2026-07-06 | |
| Investor Event Transcript | 2026-06-30 | — | |
| Investor Event Transcript | 2026-06-30 | — | |
| 8-K | 2026-06-16 | 2026-06-12 | |
| 8-K | 2026-06-02 | 2026-06-01 | |
| 8-K | 2026-05-21 | 2026-05-19 | |
| 8-K | 2026-05-11 | 2026-05-06 | |
| 8-K | 2026-05-04 | — | |
| 10-Q | 2026-05-04 | 2026-03-31 | |
| 8-K | 2026-04-14 | 2026-04-13 | |
| DEF 14A | 2026-04-06 | 2026-05-19 | |
| 10-K | 2026-02-19 | 2025-12-31 | |
| 8-K | 2026-02-19 | — | |
| 8-K | 2026-01-13 | — | |
| 8-K | 2026-01-12 | — | |
| 10-Q | 2025-10-30 | 2025-09-30 | |
| 8-K | 2025-10-30 | — | |
| 8-K | 2025-09-10 | — | |
| 10-Q | 2025-08-06 | 2025-06-30 | |
| 8-K | 2025-08-06 | — | |
| 8-K | 2025-05-16 | 2025-05-15 | |
| 8-K | 2025-05-15 | — | |
| 8-K/A | 2025-05-01 | — | |
| 8-K | 2025-05-01 | — | |
| 10-Q | 2025-05-01 | 2025-03-31 | |
| 8-K | 2025-04-30 | 2025-04-29 | |
| DEF 14A | 2025-04-01 | 2025-05-15 | |
| 8-K | 2025-03-17 | — | |
| 10-K | 2025-02-21 | 2024-12-31 | |
| 8-K | 2025-02-20 | — | |
| 8-K | 2025-02-11 | — | |
| 8-K | 2025-01-13 | — | |
| 8-K | 2024-11-08 | 2024-11-07 | |
| 10-Q | 2024-10-31 | 2024-09-30 | |
| 8-K | 2024-10-31 | — | |
| 8-K | 2024-09-26 | — | |
| 8-K | 2024-09-06 | 2024-09-05 | |
| 10-Q | 2024-08-01 | 2024-06-30 | |
| 8-K | 2024-08-01 | — | |
| 8-K | 2024-05-13 | 2024-05-08 | |
| 10-Q | 2024-05-06 | 2024-03-31 | |
| 8-K | 2024-05-06 | — | |
| 8-K | 2024-04-24 | — | |
| DEF 14A | 2024-03-27 | 2024-05-08 | |
| 8-K | 2024-02-23 | — | |
| 10-K | 2024-02-20 | 2023-12-31 | |
| 8-K | 2024-02-15 | — | |
| 8-K | 2024-01-08 | — | |
| 8-K | 2023-12-04 | 2023-11-30 | |
| 10-Q | 2023-11-07 | 2023-09-30 |
Showing 1–50 of 132 filings